- Home
- OFLX vs BCYC Comparison
OFLX vs BCYC Comparison
Compare OFLX & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OFLX | BCYC |
|---|---|---|
| Founded | 1975 | 2009 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 258.2M | 291.8M |
| IPO Year | 2005 | 2019 |
Fundamental Metrics
Financial Performance| Metric | OFLX | BCYC |
|---|---|---|
| Price | $25.80 | $3.56 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $9.50 |
| AVG Volume (30 Days) | 22.4K | ★ 412.7K |
| Earning Date | 10-28-2026 | 10-29-2026 |
| Dividend Yield | ★ 5.35% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.47 | N/A |
| Revenue | ★ $98,296,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $54.02 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $24.86 | $3.57 |
| 52 Week High | $37.92 | $9.16 |
Technical Indicators
Market Signals| Indicator | OFLX | BCYC |
|---|---|---|
| Relative Strength Index (RSI) | 48.62 | 42.96 |
| Support Level | $25.26 | $3.57 |
| Resistance Level | $26.86 | $3.95 |
| Average True Range (ATR) | 0.67 | 0.15 |
| MACD | 0.13 | 0.00 |
| Stochastic Oscillator | 68.87 | 36.84 |
Price Performance
Historical ComparisonAbout OFLX Omega Flex Inc.
Omega Flex Inc is a manufacturer of flexible metal hoses, which is used in a variety of ways to carry gases and liquids within their particular applications. Omega sells its products under the TracPipe, CounterStrike, DoubleTrac, DEF-Trac and MediTrac brands. It serves various markets which include construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. Geographically Omega Flex, Inc operates in the United States. The company derives revenues from the manufacture and sale of flexible metal hose and accessories.
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.